Publicacions
-
Martinez-Lage M, Torres-Ruiz R, Puig-Serra P, Moreno-Gaona P, Martin MC, Moya FJ, Quintana-Bustamante O, Garcia-Silva S, Carcaboso AM, Petazzi P, Bueno C, Mora J, Peinado H, Segovia JC, Menendez P and Rodriguez-Perales S.
In vivo CRISPR/Cas9 targeting of fusion oncogenes for selective elimination of cancer cells
NATURE COMMUNICATIONS . 11(1): 5060-5060. Nº de cites: 68
-
Sánchez-Molina S, Figuerola-Bou E, Blanco ME, Sanchez-Jimenez M, Táboas-Outón P, Gomez-Gonzalez S, Ballaré C, García-Domínguez DJ, Prada-Varela E, Hontecillas-Prieto L, Carcaboso AM, Tirado ÓM, Hernandez-Muñoz MI, de Álava E, Lavarino C, Di Croce L and Mora J.
RING1B recruits EWSR1-FLI1 and cooperates in the remodeling of chromatin necessary for Ewing sarcoma tumorigenesis
Science Advances . 6(43): 3058. Nº de cites: 27
-
Bukchin, A, Sanchez-Navarro, M, Carrera, A, Teixido, M, Carcaboso AM, Giralt, E and Sosnik, A.
Amphiphilic Polymeric Nanoparticles Modified with a Retro-Enantio Peptide Shuttle Target the Brain of Mice
CHEMISTRY OF MATERIALS . 32(18): 7679-7693. Nº de cites: 18
-
Zugbi S, Ganiewich D, Bhattacharyya A, Aschero R, Ottaviani D, Sampor C, Cafferata EG, Mena M, Sgroi M, Winter U, Lamas G, Suñol M, Daroqui M, Baialardo E, Salas B, Das A, Fandiño A, Francis JH, Lubieniecki F, Lavarino C, Garippa R, Podhjacer OL, Abramson DH, Radvanyi F, Chantada G, Llera AS and Schaiquevich P.
Clinical, Genomic, and Pharmacological Study of MYCN-Amplified RB1 Wild-Type Metastatic Retinoblastoma
Cancers . 12(9): . Nº de cites: 29
-
Wiese M, Hamdan FH, Kubiak K, Diederichs C, Gielen GH, Nussbaumer G, Carcaboso AM, Hulleman E, Johnsen SA and Kramm CM.
Combined treatment with CBP and BET inhibitors reverses inadvertent activation of detrimental super enhancer programs in DIPG cells
CELL DEATH & DISEASE . 11(8): 673-673. Nº de cites: 41
-
Castillo H, Monterrubio C, Pascual-Pastó G, Gomez-Gonzalez S, Garcia-Dominguez DJ, Hontecillas-Prieto L, Resa-Parés C, Burgeño-Sandoval V, Paco-Mercader S, Gene-Olaciregui N, Vilà-Ubach M, Restrepo-Perdomo C, Cuadrado-Vilanova M, Balaguer-Lluna L, Pérez-Jaume S, Castañeda-Heredia A, Santa-María López V, Roldan-Molina M, Suñol M, de Alava E, Mora J, Lavarino C and Carcaboso AM.
Treatment-driven selection of chemoresistant Ewing sarcoma tumors with limited drug distribution
JOURNAL OF CONTROLLED RELEASE . 324: 440-449. Nº de cites: 7
-
Chen KY, Bush K, Klein RH, Cervantes V, Lewis N, Naqvi A, Carcaboso AM, Lechpammer M and Knoepfler PS.
Reciprocal H3.3 gene editing identifies K27M and G34R mechanisms in pediatric glioma including NOTCH signaling
Communications Biology . 3(1): 363-363. Nº de cites: 36
-
Bossacoma F, Cuadrado-Vilanova M, Vinent-Genestar J, Correa MG, Gavrus D, Castillo H, Català-Mora J, Mora J, Schaiquevich P, Chantada G and Carcaboso AM.
Optimizing the storage of chemotherapeutics for ophthalmic oncology: stability of topotecan solution for intravitreal injection
OPHTHALMIC GENETICS . 41(4): 397-400. Nº de cites: 2
-
Fernández-Rodríguez J, Morales-La Madrid A, Gel B, Castañeda-Heredia A, Salvador-Hernandez H, Martínez-Iniesta M, Moutinho C, Morata J, Heyn H, Blanco I, Creus-Bachiller E, Capella G, Farré L, Vidal A, Soldado F, Krauel L, Suñol M, Serra E, Villanueva A and Lázaro C.
Use of patient derived orthotopic xenograft models for real-time therapy guidance in a pediatric sporadic malignant peripheral nerve sheath tumor
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY . 12: . Nº de cites: 6
-
Meel MH, de Gooijer MC, Metselaar DS, Sewing ACP, Zwaan K, Waranecki P, Breur M, Buil LCM, Lagerweij T, Wedekind LE, Twisk JWR, Koster J, Hashizume R, Raabe EH, Carcaboso AM, Bugiani M, Phoenix TN, van Tellingen O, van Vuurden DG, Kaspers GJL and Hulleman E.
Combined Therapy of AXL and HDAC Inhibition Reverses Mesenchymal Transition in Diffuse Intrinsic Pontine Glioma
CLINICAL CANCER RESEARCH . 26(13): 3319-3332. Nº de cites: 43